Nectar Lifesciences Stock Price Analysis and Quick Research Report. Is Nectar Lifesciences an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Nectar Lifesciences. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Nectar Lifesciences has a PE ratio of -1.96731121666604 which is low and comparatively undervalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Nectar Lifesciences has ROA of 0.2299% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Nectar Lifesciences has a Current ratio of 1.3197.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Nectar Lifesciences has a ROE of 0.4688%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Nectar Lifesciences has a Debt to Equity ratio of 0.5944 which means that the company has low proportion of debt in its capital.

• Sales growth: Nectar Lifesciences has reported revenue growth of 10.5283% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Nectar Lifesciences for the current financial year is 8.99954040351858%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Nectar Lifesciences is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Nectar Lifesciences is Rs -8.0211. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Nectar Lifesciences in Ticker for free. Also, one can get the intrinsic value of Nectar Lifesciences by using Valuation Calculators, which are available with a Finology ONE subscription. 

Nectar Lifesciences FAQs

Q1. What is Nectar Lifesciences share price today?
Ans: The current share price of Nectar Lifesciences is Rs 15.78.

Q2. What is the market capitalisation of Nectar Lifesciences?
Ans: Nectar Lifesciences has a market capitalisation of Rs 353.88381066 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Nectar Lifesciences?
Ans: The PE ratio of Nectar Lifesciences is -1.96731121666604 and the P/B ratio of Nectar Lifesciences is 0.396339013020415, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Nectar Lifesciences share?
Ans: The 52-week high share price of Nectar Lifesciences is Rs 54.99, and the 52-week low share price of Nectar Lifesciences is Rs 13.05.

Q5. Does Nectar Lifesciences pay dividends?
Ans: Currently, Nectar Lifesciences does not pay dividends. Dividend yield of Nectar Lifesciences is around 0%.

Q6. What are the face value and book value of Nectar Lifesciences shares?
Ans: The face value of Nectar Lifesciences shares is Rs 1, while the book value per share of Nectar Lifesciences is around Rs 39.8144. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Nectar Lifesciences?
Ans: Nectar Lifesciences has a total debt of Rs 635.537 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Nectar Lifesciences?
Ans: The ROE of Nectar Lifesciences is 0.4688% and ROCE of Nectar Lifesciences is 6.5377%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Nectar Lifesciences a good buy for the long term?
Ans: The Nectar Lifesciences long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Nectar Lifesciences undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Nectar Lifesciences appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Nectar Lifesciences’s financials?
Ans: You can review Nectar Lifesciences’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.